Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON33094
NL-OMON33094
Not yet recruiting
Not Applicable

Effects of growth hormone (GH) replacement therapy in GH deficient adult childhood cancer survivors on organ size and microvascularisation of kidney and skin. - Effects of GH replacement therapy on organ size and microvascularisation.

ovo Nordisk0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsgrowth hormone deficiency1002111210038430

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
growth hormone deficiency
Sponsor
ovo Nordisk
Enrollment
50
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
ovo Nordisk

Eligibility Criteria

Inclusion Criteria

  • •childhood cancer survivors who have been treated with cranial irradiation
  • •growth hormone deficient
  • •age \> 18 years
  • •\> 5 years off tumor treatment

Exclusion Criteria

  • •growth hormone replacement therapy in the last 12 months
  • •current treatment for second malignancy
  • •severe mental disorder/dementia/inability of legal consent
  • •drug abuse/dependence
  • •for women: pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Growth hormone deficiency and clotting
ISRCTN59234325eeds Teaching Hospitals NHS Trust (UK)140
Completed
Not Applicable
Growth Hormone (GH) Replacement Therapy Decreased Plasma Diacron-reactive Oxygen Metabolites levels and subsequently, improved Endothelial Function as Assessed by Peripheral Arterial Tonometry in Japanese Patient with growth Hormone deficiencyGrowth Hormone Deficiency
JPRN-UMIN000025223Dokkyo Medical University15
Completed
Not Applicable
The effects of growth hormone (GH) on the results of echocardiography in patients with heart failure (HF) four weeks after myocardial infarction (MI)
IRCT201704083035N1Vice chancellor for research, School of Medicine, Isfahan University of Medical Sciences32
Completed
Not Applicable
Efficacy and safety of growth hormone treatment in short children born small for gestational age; effects of growth hormone levels on growth, insulin sensitivity and body compositioSmall for gestational age (SGA), children with persistent short staturePregnancy and ChildbirthSlow foetal growth
ISRCTN65230311Erasmus Medical Center (The Netherlands)157
Active, not recruiting
Not Applicable
Effects of growth hormone treatment to patients with partial growth hormone deficiency, with special emphasis on acute phase proteins and pro-inflammatory cytokines.
EUCTR2005-004478-26-SEKarolinska universitetssjukhuset